Biosimilar Newsletter Archive

  1. 04.17.25 -- AI Performance Management In Biologic And Drug Development 4/17/2025
    04/17/25 Biosimilar Development Newsletter
  2. 04.10.25 -- U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance 4/10/2025
    04/10/25 Biosimilar Development Newsletter
  3. 04.03.25 -- Optimize Downstream Separation With Tagless Proteins 4/3/2025
    04/03/25 Biosimilar Development Newsletter
  4. 03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development 3/27/2025
    03/27/25 Biosimilar Development Newsletter
  5. 03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture 3/20/2025
    03/20/25 Biosimilar Development Newsletter
  6. 03.20.25 -- Comparison Of WFI Production Methods 3/20/2025
    03/20/25 Biosimilar Development Newsletter
  7. 03.13.25 -- Optimize Your High Concentration Biologic Production Process 3/13/2025

    03/13/25 Biosimilar Development Newsletter

  8. 03.13.25 -- Emerging Trends In mAbs Manufacturing 3/13/2025
    03/13/25 Biosimilar Development Newsletter
  9. 03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars 3/6/2025
    03/06/25 Biosimilar Development Newsletter
  10. 02.27.25 -- A New Approach For Minimizing Human Errors In Biopharmaceuticals 2/27/2025
    02/27/25 Biosimilar Development Newsletter